ARTELO BIOSCIENCES, INC. Intellectual Property Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute dated January 4, 2019
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
2019
First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute, dated as of January 4, 2019
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
2019
License Agreement with Stony Brook University, by and between the Company and Stony Brook University, dated January 18, 2018
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
License Agreement with Stony Brook University, by and between the Company and Stony Brook University, dated January 18, 2018
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
Exclusive License Agreement between The Research Foundation For The State University of New York and Artelo Biosciences, Inc.
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
Material and Data Transfer, Option and License Agreement dated December 20, 2017 between the Company and NEOMED Institute
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2018
Material and Data Transfer, Option and License Agreement dated December 20, 2017 between the Company and NEOMED Institute
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2017
Exclusive Patent License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
CA
2017
Amendment Dated August 1, 2017 to the Exclusive License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
CA
2017
Exclusive License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc
License Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
CA
2017